Wright Lassiter III - 18 May 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 May 2022, 16:26:58 UTC
Prior SEC filing
10 May 2022
Next SEC filing
08 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
William J. O'Shaughnessy, Jr., Attorney-in-fact for Wright Lassiter, III

Key filing fact

Wright Lassiter III filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 20 May 2022.

Key facts

  • This page summarizes Wright Lassiter III's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 May 2022, 16:26.

Change

  • Previous filing in this sequence was filed on 10 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Award

Transaction value
$0
Shares
+1,292
Change %
+39%
Price
$0.000000
Shares after
4,633
Date
18 May 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an award of restricted share units.

Footnote F2

The amount includes approximately 60 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .